Center for Environmental and Health Sciences, Hokkaido University, Sapporo, Japan.
Department of Social Medicine, Asahikawa Medical University, Asahikawa, Japan.
PLoS One. 2022 Aug 22;17(8):e0272968. doi: 10.1371/journal.pone.0272968. eCollection 2022.
Maternal intake of folic acid supplements is reportedly associated with the risk of early-onset allergies in offspring. However, only a few studies have considered the intake of both folic acid supplements and dietary folate. Here, the relationship between maternal intake of folic acid supplements and allergic symptoms such as wheeze and eczema in offspring was analyzed while considering dietary folate intake. We examined 84,361 mothers and 85,114 children in the Japan Environment and Children's Study. The participants were divided into three groups depending on maternal folic acid supplementation ("no use," "occasional use," and "daily use"). Each group was then subdivided into three groups based on total folic acid and dietary folate intake. Outcomes were determined considering the wheeze and eczema status of each child at the age of 2 years. The status was based on the International Study of Asthma and Allergies in Childhood. It was found that 22.1% of the mothers took folic acid supplements daily. In contrast, 56.3% of the mothers did not take these supplements. Maternal intake of folic acid supplements was not associated with wheeze and eczema in the offspring. In contrast, only dietary folate intake was positively associated with wheeze at the age of 2 (adjusted odds ratio, 1.103; 95% confidence interval, 1.003-1.212). However, there is no scientific evidence of a biological mechanism that clarifies this result. Potential confounders such as other nutrition, outdoor/indoor air pollution, and genetic factors may have affected the results. Therefore, further studies on the association between maternal intake of folic acid and allergic symptoms at the age of 3 or above are needed to confirm the results of this study. Trial registration UMIN Clinical Trials Registry (number: UMIN000030786).
据报道,母亲摄入叶酸补充剂与后代早发性过敏的风险有关。然而,只有少数研究考虑了叶酸补充剂和饮食叶酸的摄入量。在这里,我们分析了母亲摄入叶酸补充剂与后代喘息和湿疹等过敏症状之间的关系,同时考虑了饮食叶酸的摄入量。我们检查了日本环境与儿童研究中的 84361 名母亲和 85114 名儿童。根据母亲叶酸补充剂的使用情况(“不使用”、“偶尔使用”和“每日使用”),将参与者分为三组。然后,根据总叶酸和饮食叶酸的摄入量,将每组进一步分为三组。考虑到每个孩子在 2 岁时的喘息和湿疹状况来确定结果。该状况是基于儿童国际哮喘和过敏研究。结果发现,22.1%的母亲每天服用叶酸补充剂。相比之下,56.3%的母亲不服用这些补充剂。母亲摄入叶酸补充剂与后代的喘息和湿疹无关。相比之下,只有饮食叶酸的摄入量与 2 岁时的喘息呈正相关(调整后的优势比,1.103;95%置信区间,1.003-1.212)。然而,目前没有科学证据表明有明确这一结果的生物学机制。其他营养物质、室外/室内空气污染和遗传因素等潜在混杂因素可能影响了结果。因此,需要进一步研究母亲摄入叶酸与 3 岁及以上儿童过敏症状之间的关联,以证实本研究的结果。
试验注册 UMIN 临床试验注册(编号:UMIN000030786)。